Cargando…
A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V. Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159462/ http://dx.doi.org/10.1016/S0169-5002(21)00276-2 |
| _version_ | 1783700093022502912 |
|---|---|
| author | Church, Matt Taylor, Paul Summers, Yvonne Califano, Raffaele Rafee, Shereen Dixon, Mairead Clarke, Lisa Cove-Smith, Laura |
| author_facet | Church, Matt Taylor, Paul Summers, Yvonne Califano, Raffaele Rafee, Shereen Dixon, Mairead Clarke, Lisa Cove-Smith, Laura |
| author_sort | Church, Matt |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8159462 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier B.V. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81594622021-05-28 A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic Church, Matt Taylor, Paul Summers, Yvonne Califano, Raffaele Rafee, Shereen Dixon, Mairead Clarke, Lisa Cove-Smith, Laura Lung Cancer Mesothelioma Elsevier B.V. Published by Elsevier B.V. 2021-06 2021-05-28 /pmc/articles/PMC8159462/ http://dx.doi.org/10.1016/S0169-5002(21)00276-2 Text en Copyright © 2021 Elsevier B.V. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Mesothelioma Church, Matt Taylor, Paul Summers, Yvonne Califano, Raffaele Rafee, Shereen Dixon, Mairead Clarke, Lisa Cove-Smith, Laura A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic |
| title | A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic |
| title_full | A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic |
| title_fullStr | A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic |
| title_full_unstemmed | A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic |
| title_short | A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic |
| title_sort | real-world experience of second-line nivolumab in mesothelioma patients during the covid-19 pandemic |
| topic | Mesothelioma |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159462/ http://dx.doi.org/10.1016/S0169-5002(21)00276-2 |
| work_keys_str_mv | AT churchmatt arealworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT taylorpaul arealworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT summersyvonne arealworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT califanoraffaele arealworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT rafeeshereen arealworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT dixonmairead arealworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT clarkelisa arealworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT covesmithlaura arealworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT churchmatt realworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT taylorpaul realworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT summersyvonne realworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT califanoraffaele realworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT rafeeshereen realworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT dixonmairead realworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT clarkelisa realworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic AT covesmithlaura realworldexperienceofsecondlinenivolumabinmesotheliomapatientsduringthecovid19pandemic |